December 17, 2014 5:04 PM ET

Capital Markets

Company Overview of MedImmune Ventures, Inc.

Executive Profile

Michael J. Gutch Ph.D.

Managing Director, MedImmune Ventures, Inc.
AgeTotal Calculated CompensationThis person is connected to 4 Board Members in 4 different organizations across 7 different industries.

See Board Relationships


Dr. Michael J. Gutch, also known as Mike, Ph.D., is the Managing Director at MedImmune Ventures, Inc. Dr. Gutch joined MedImmune Ventures in September 2011. Previously, he served as an Executive of H.I.G. Ventures, LLC. He joined H.I.G.’s life sciences team on April 7, 2008. He served as a Manager of the Corporate Finance and Investment Banking Group of Eli Lilly and Company, where he focused on mergers and acquisitions and licensing transactions. He is a Board Observer ...

Corporate Headquarters

One MedImmune Way
Gaithersburg, Maryland 20878

United States

Phone: 301-398-3000
Fax: 301-398-8170

Board Members Memberships

Former Director
Board Observer
Board Observer


State University of New York
Indiana University, Bloomington

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MedImmune Ventures, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at